Bausch Health Companies | VRX - Debt

Stock Price
7.47
Daily Change
-0.02 -0.27%
Monthly
-6.27%
Yearly
14.40%
Q2 Forecast
7.31

Bausch Health Companies reported $20.85B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Amgen USD 54.6B 17M Dec/2025
ANI Pharmaceuticals USD 617.04M 3.28M Dec/2025
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Bausch Health Companies USD 20.85B 191M Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Corcept Therapeutics USD 6.11M 251K Dec/2025
Danaher USD 18.48B 66M Mar/2026
Drreddys Laboratories INR 67.73B 19.09B Dec/2025
Eli Lilly USD 42.5B 3.6M Dec/2025
Gilead Sciences USD 24.94B 5M Dec/2025
Nektar Therapeutics USD 0 0 Jun/2022
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.64B 4.5M Dec/2025
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.08B 38.27M Dec/2025
Supernus Pharmaceuticals USD 40.98M 1.23M Dec/2025
Vertex Pharmaceuticals USD 1.99B 44M Mar/2026
Zoetis USD 9.24B 1.96B Dec/2025